Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07247136 · ClinicalTrials.gov registry record · NA
Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System
A NA study of Urinary Urge Incontinence, sponsored by Neuspera Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07247136: Recruiting NA study of Urinary Urge Incontinence, sponsored by Neuspera Medical.
NCT07247136 is a NA study of Urinary Urge Incontinence that is actively recruiting participants, run by Neuspera Medical. The registered enrollment target is 30 participants, below the 97-participant average among 6 other Urinary Urge Incontinence trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07247136, a NA study of Urinary Urge Incontinence, is actively recruiting participants, sponsored by Neuspera Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Single-arm study conducted in participants for the treatment of urinary urge incontinence in patients who have failed, could not tolerate, or were not a candidate for more conservative treatments. The objective of the study is to assess the effectiveness of 30-minutes daily therapeutic stimulation with the Neuspera System.
Primary Outcome
Proportion of Subjects experiencing a device- and/or procedure-related Adverse events
Conditions Studied
Interventions
- DEVICE Neuspera Implantable Sacral Neuromodulation System
Study Locations (1)
South Carolina
- Southern Urogynecology, LLC - West Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-11-19 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT07247136 shows while recruiting
NCT07247136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 97-participant average among 6 other Urinary Urge Incontinence trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Urinary Urge Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Neuspera Implantable Sacral Neuromodulation System is the first listed.
NCT07247136 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT07247136 about?
NCT07247136 is a clinical study titled "Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System". Single-arm study conducted in participants for the treatment of urinary urge incontinence in patients who have failed, could not tolerate, or were not a candidate for more conservative treatments. The objective of the study is to assess the effectiveness of 30-minutes daily therapeutic stimulation ...
What is the current status of trial NCT07247136?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-11-19. Estimated completion is 2026-11.
What conditions does trial NCT07247136 study?
This clinical trial studies the following conditions: Urinary Urge Incontinence.
What interventions are being tested in trial NCT07247136?
The interventions under investigation include: Neuspera Implantable Sacral Neuromodulation System (DEVICE).
Who is sponsoring clinical trial NCT07247136?
This trial is sponsored by Neuspera Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07247136 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Urge Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
RESTORE: An RCT to Evaluate the Efficacy of the Revi System
ACTIVE NOT RECRUITING · NA
-
InterStim Therapy Programming Study
COMPLETED · NA
-
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
RECRUITING · Phase 2
-
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
RECRUITING · Phase 4
-
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI